首页 | 本学科首页   官方微博 | 高级检索  
     


Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection,analysis
Affiliation:1. Monash Children’s Hospital, Clayton, Melbourne, Australia;2. Royal Children’s Hospital, Parkville, Victoria, Australia;3. Italian Medicines Agency (AIFA), Rome, Italy;4. Murdoch Childrens Research Institute, Parkville, Victoria, Australia;5. Department of Paediatrics, Monash University, Clayton, Victoria, Australia;6. The Brighton Collaboration Foundation, Basel, Switzerland;7. Uppsala Monitoring Centre, Uppsala, Sweden;8. Independent Consultant, Bethesda, MD, USA;9. Department of Vaccines Control, National Agency for Medicines and Medical Devices, Tirana, Albania;10. Pharmacovigilance Regional Centre of Lombardy, Italy;11. Children’s Mercy Hospital, Kansas City, MO, USA;12. Ann & Robert H. Lurie Children’s Hospital of Chicago, USA;13. Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada;14. Hospital Nacional de Niños “Dr. Carlos Sáenz Herrera, San José, Costa Rica;15. Independent Consultant Vaccinologist, Wakefield, RI, USA;p. Boston Children’s Hospital, Boston, USA;q. CHU Sainte-Justine, Montreal, Canada;r. Post Graduate Institute of Medical Education and Research (PGIMER) – Chandigarh, India;s. University of Basel Children’s Hospital, Basel, Switzerland;t. Department of Paediatrics, Melbourne University, Parkville, Victoria, Australia
Abstract:
Keywords:Kawasaki disease  Adverse event  Immunisation  Guidelines  Case definition
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号